Neuroanatomic substrates of late-life mental disorders

Journal of Geriatric Psychiatry and Neurology

Volumn 12, Issue 3, 1999, Pages 95-106

  Narayan, Meena ^a   Bremner, J Douglas ^a   Kumar, Anand ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL GANGLION; BRAIN SIZE; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID; DEGENERATIVE DISEASE; DEPRESSION; FRONTAL LOBE; GERONTOPSYCHIATRY; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; METHODOLOGY; MODEL; MORPHOMETRICS; NEUROANATOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; TEMPORAL LOBE; THALAMUS; VOLUMETRY;

EID: 0033385750     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879901200303     Document Type: Article

References (105)

1. Coffey CE, Lucke JF, Saxton JA, et al. Sex differences in brain aging: a quantitative magnetic resonance imaging study. Arch Neurol 1998; 55:169-179.
2. Matsumae M, Kikinis R, Morocz, et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. J Neurosurg 1996; 84:982-991.
3. Passe TJ, Rajagopalan P, Tupler LA, et al. Age and sex effects on brain morphology. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21:1231-1237.
4. Steffens DC. MRI and MRS in dementia. In: Krishnan KRR, Doraiswamy PM, eds. Brain imaging in clinical psychiatry. New York: Marcel Dekker, 1997:503-532.
5. Sheline YI, Wang PW, Gado MH, et al. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996; 93:3908-3913.
6. Kumar A, Jin Z, Bilker W, et al. Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI. Proc Natl Acad Sci U S A 1998; 95:7654-7658.
7. Kumar A, Schweizer E, Jin Z, et al. Neuroanatomical substrates of late-life minor depression. A quantitative magnetic resonance imaging study. Arch Neurol 1997; 54:613-617.
8. Krishnan KR, McDonald WM, Doraiswamy PM, et al. Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci 1993; 243:41-46.
9. Kumar A, Bilker W, Jin Z, et al. Age of onset of depression and quantitative neuroanatomic measures: absence of specific correlates. Psychiatry Res (Neuroimaging) 1999 (in press).
10. Pantel J, Schroder J, Essig M, et al. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord 1997; 42:69-83.
11. Howard RJ, Almeida O, Levy R, et al. Quantitative magnetic resonance imaging volumetry distinguishes delusional disorder from late-onset schizophrenia. Br J Psychiatry 1994; 165:474-480.
12. Corey-Bloom J, Jernigan T, Archibald S, et al. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry 1995; 152:447-449.
13. Kumar A, Miller M, Ewbank W, et al. Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am J Geriatr Psychiatry 1997; 5:15-25.
14. McCarthy G, Puce A, Constable RT, et al. Activation of human prefrontal cortex during spatial and nonspatial working memory tasks measured by functional MRI. Cerebral Cortex 1996; 6:600-611.
15. Fuster JM. Frontal lobe syndromes. In: Fogel BS, Schiffer RB, Rao SM, eds. Neuropsychiatry. Baltimore: Williams & Wilkins, 1996:407-413.
16. Coffey CE, Wilkinson WE, Weiner RD, et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993; 50:7-16.
17. Krishnan KRR, Doraiswamy PM, Lurie SN, et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry 1992; 49:553-557.
18. Kumar A, Bilker W, Jin Z, Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. [Abstract 601.1]. In: Annual Meeting for the Society for Neuroscience. Washington, DC: Society for Neuroscience, 1998 and J Neuropsychopharm (in press).
19. Kumar A, Bilker W, Jin Z, Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. [Abstract 601.1]. In: Annual Meeting for the Society for Neuroscience. Washington, DC: Society for Neuroscience, 1998 and J Neuropsychopharm (in press).
20. Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Lancet 1997; 386:824-827.
21. Cowell PE, Turetsky BI, Gur RC, et al. Sex differences in aging of the human frontal and temporal lobes. J Neurosci 1994; 14:4748-4755.
22. Frisoni GB, Beltramello A, Geroldi C, et al. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry 1996; 61:157-165.
23. Convit A, de Leon MJ, Hoptman MJ, et al. Age-related changes in brain: I. Magnetic resonance imaging measures of temporal lobe volumes in normal subjects. Psychiatr Q 1995; 66:343-355.
24. Sullivan EV, Marsh L, Mathalon DH, et al. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 1995; 16:591-606.
25. Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1:69-73.
26. De Leon MJ, George AE, Stylopoulos LA, et al. The atrophic hippocampus. Lancet 1989; 2:672-673.
27. Jack CR, Peterson RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42:183.
28. Mauri M, Sibilla L, Bono G, et al. The role of morpho-volumetric and memory correlations in the diagnosis of early Alzheimer dementia. J Neurol 1998; 245:525-530.
29. Smith CD, Malcein M, Meurer K, et al. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease. J Neuroimaging 1999; 9:2-9.
30. Desmond PM, O'Brien JT, Tress BM, et al. Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. Aust N Z J Med 1994; 24:547-553.
31. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41:1006-1009.
32. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49:786-794.
33. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994; 15:929-937.
34. Laakso MP, Partanen K, Lehtovirta M, et al. MRI of amygdala fails to diagnose early Alzheimer's disease. Neuroreport 1995; 6:2414-2418.
35. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996; 119:2001-2007.
36. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997; 48:1297-1304.
37. De Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993; 14:897-906.
38. Convit A, de Leon MJ, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997; 18:131-138.
39. Jack Jr CR, Petersen RC, Xu YC, et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol 1998; 43:303-310.
40. Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998; 44:288-291.
41. Juottonen K, Lehtovirta M, Helisalmi S, et al. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatry 1998; 65:322-327.
42. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995; 67:65-72.
43. Sapolsky RM, Uno H, Rebert CS, et al. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10:2897-2902.
44. Magarinos AM, Verdugo JM, McEwen BS. Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci U S A 1997; 94:14002-14008.
45. Gould E, Tanapat P, McEwen BS, et al. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci U S A 1998; 95:3168-3171.
46. Rothschild AJ, Benes F, Woods B, et al. Relationships between brain CT scan findings and cortisol in psychotic and non psychotic depressed patients. Biol Psychiatry 1989; 26:565-575.
47. Axelson DA, Doraiswamy PM, McDonald WM, et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 1993; 47:163-173.
48. Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry 1999 (in press).
49. Ohnuma T, Kimura M, Takahashi T, et al. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin Neurosci 1997; 51:9-15.
50. Woodruff PW, Wright IC, Shuriquie N, et al. Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychol Med 1997; 27:1257-1266.
51. Barta PE, Pearlson GD, Powers RE, et al. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990; 147:1457-1462.
52. Barta PE, Powers RE, Aylward EH, et al. Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls. Psychiatry Res 1997; 68:65-75.
53. Starkstein SE, Petracca G, Chemerinski E, et al. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord 1998; 13:29-33.
54. Fetoni V, Soliveri P, Monza D, et al. Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999; 66:541-544.
55. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology 1989; 39:349-354.
56. Parashos IA, Tupler LA, Blitchington T, et al. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res 1998; 84:7-15.
57. Jeste DV, McAdams LA, Palmer BW, et al. Relationship of neuropsychological and MRI measures to age of onset of schizophrenia. Acta Psychiatr Scand 1998; 98:156-164.
58. Keshavan MS, Bagwell WW, Haas GL, et al. Changes in caudate volume with neuroleptic treatment. Lancet 1994; 344:1434.
59. Gur RE, Maany V, Mozley PD, et al. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155:1711-1717.
60. Fazekas F, Niederkorn K, Schmidt R, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19:1285-1288.
61. Fazekas F, Schmidt R, Kleinert R, et al. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm 1998; 53:31-39.
62. Guttmann CR, Jolesz FA, Kikinis R, et al. White matter changes with normal aging. Neurology 1998; 50:972-978.
63. Fazekas F, Barkhof F, Filippi M. Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64:S2-5.
64. George AE, de Leon MJ, Kalnin A, et al. Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol 1986; 7:567-570.
65. Bennett DA, Gilley DW, Wilson RS, et al. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol 1992; 239:186-190.
66. Bots ML, van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341:1232-1237.
67. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27:1274-1282.
68. Ylikoski A, Erkinjuntti T, Raininko R, et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1996; 27:1274-1282.
69. Coffey CE, Figiel GS, Djang WT, et al. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci 1989; 1:135-144.
70. Coffey CE, Figiel GS, Djang WT, et al. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990; 147:187-189.
71. Greenwald BS, Kramer-Ginsberg E, Krishnan RR, et al. MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996; 153:1212-1215.
72. Rabins PV, Pearlson GD, Aylward E, et al. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 1991; 148:617-620.
73. Zubenko GS, Sullivan P, Nelson JP, et al. Brain imaging abnormalities in mental disorders of late life. Arch Neurol 1990; 47:1107-1111.
74. Greenwald BS, Kramer-Ginsberg E, Krishnan KR, et al. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 1998; 29:613-617.
75. Iidaka T, Nakajima T, Kawamoto K, et al. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. Eur Neurol 1996; 36:293-299.
76. Figiel GS, Krishnan KR, Doraiswamy PM, et al. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 1991; 12:245-247.
77. Lesser IM, Boone KB, Mehringer CM, et al. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996; 153:1280-1287.
78. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996; 46:1567-1574.
79. Linn BS, Linn MW, Gural L. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16:622-626.
80. Hickie I, Scott E, Mitchell P, et al. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37:151-160.
81. Simpson S, Baldwin RC, Jackson A, et al. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998; 28:1015-1026.
82. Figiel GS, Coffey CE, Djang WT, et al. Brain magnetic resonance imaging findings in ECT-induced delirium. J Neuropsychiatry Clin Neurosci 1990; 2:53-58.
83. Figiel GS, Krishnan KR, Breitner JC, et al. Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions. J Neuropsychiatry Clin Neurosci 1989; 1:188-190.
84. Kramer-Ginsberg E, Greenwald BS, Krishnan KR, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1999; 156:438-444.
85. Cahn DA, Malloy PF, Salloway S, et al. Subcortical hyperintensities on MRI and activities of daily living in geriatric depression. Neurosciences 1996; 8:404-411.
86. Lesser IM, Miller BL, Swartz JR, et al. Brain imaging in late-life schizophrenia and related psychoses. Schizophr Bull 1993; 19:773-782.
87. Symonds LL, Olichney JM, Jernigan TL, et al. Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. J Neuropsychiatry Clin Neurosci 1997; 9:251-258.
88. Baxter LR Jr, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250.
89. Bench CJ, Friston KJ, Brown RG, et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23:579-590.
90. Bremner JD, Innis RB, Salomon RM, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997; 54:364-374.
91. Rajkowska G, Miguel-Hidalga JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45:1085-1098.
92. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998; 95:13290-13295.
93. Bremner JD. Does stress damage the brain? Biol Psychiatry 1999; 45:797-805.
94. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986; 7:284-301.
95. Lopez JF, Chalmers DT, Little KY, et al. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998; 43:547-573.
96. Duman RS, Heninger GR, Nestler EJ. Amolecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54:597-606.
97. Duman RS, Charney DS. Cell atrophy and loss in major depression. Biol Psychiatry 1999; 45:1083-1084.
98. Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986; 17:1084-1089.
99. Awad IA, Johnson PC, Spetzler RF, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986; 17:1090-1097.
100. Braffman BH, Zimmerman RA, Trojanowski JQ, et al. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol 1988; 151:559-566.
101. Chimowitz MI, Estes ML, Furlan AJ, et al. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49:747-752.
102. Boyko OB, Alston SR, Fuller GN. Utility of postmortem magnetic resonance imaging in clinical neuropathology. Arch Pathol Lab Med 1994; 118:219-225.
103. Selemon LD, Goldman-Rakic PS. Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior. J Neurosci 1988; 8:4049-4068.
104. Arango V, Underwood MD, Gubbi AV, et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995; 688:121-133.
105. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41:86-106.